{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T22:06:43Z","timestamp":1780438003277,"version":"3.54.1"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>We investigated the characteristics of regulatory T cells in adult-onset Still's disease (AOSD) with a focus on their plasticity, stability and relationship to disease severity. The proportion of circulating CD4+CD25+forkhead box protein 3 (FoxP3+) cells (Tregs) and intracellular expression of effector cytokines, including interferon (IFN)-\u03b3, interleukin (IL)-17 and IL-4, was analysed in 27 untreated patients with AOSD (acute AOSD), 11 of the 27 patients after remission and 16 healthy controls (HC) using flow cytometry. The suppressive ability of Tregs was also evaluated. Regression analyses of the results were performed. The proportion of Tregs was significantly lower in patients with acute AOSD than in the HC. The expression levels of IFN-\u03b3, IL-17 and IL-4 in Tregs were significantly increased in patients with acute AOSD. IFN-\u03b3 and IL-4 expression levels were inversely correlated with the proportion of Tregs and positively correlated with serum ferritin levels. Decreased expression of FoxP3 in CD4+CD25+ cells, which was correlated with increased expression of IL-17, and impaired suppressive function were observed in Tregs in acute AOSD. However, these aberrant findings in Tregs, including the reduced circulating proportion and functional ability and altered intracellular expression levels of cytokines and FoxP3, were significantly improved after remission. In acute AOSD, Tregs show plastic changes, including effector cytokine production and reductions in their proportion and functional activity. IFN-\u03b3 and IL-4 expression levels in Tregs may be associated with disease severity. Also, down-regulation of FoxP3 may be related to IL-17 expression in Tregs. Importantly, the stability of Tregs can be restored in remission.<\/jats:p>","DOI":"10.1111\/cei.13648","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T13:41:48Z","timestamp":1627479708000},"page":"184-195","source":"Crossref","is-referenced-by-count":13,"title":["Circulating regulatory T cells in adult-onset Still's disease: Focusing on their plasticity and stability"],"prefix":"10.1093","volume":"206","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7100-1121","authenticated-orcid":false,"given":"Yasuhiro","family":"Shimojima","sequence":"first","affiliation":[{"name":"Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Ichikawa","sequence":"additional","affiliation":[{"name":"Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Kishida","sequence":"additional","affiliation":[{"name":"Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Takamatsu","sequence":"additional","affiliation":[{"name":"Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Sekijima","sequence":"additional","affiliation":[{"name":"Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,8,12]]},"reference":[{"key":"2021121100032006500_cei13648-bib-0001","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2018.07.018","article-title":"A comprehensive review on adult onset Still's disease","volume":"93","author":"Giacomelli","year":"2018","journal-title":"J Autoimmun"},{"key":"2021121100032006500_cei13648-bib-0002","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41584-018-0081-x","article-title":"Mechanisms, biomarkers and targets for adult-onset Still's disease","volume":"14","author":"Feist","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"2021121100032006500_cei13648-bib-0003","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","article-title":"Adult-onset Still's disease","volume":"13","author":"Gerfaud-Valentin","year":"2014","journal-title":"Autoimmun Rev"},{"key":"2021121100032006500_cei13648-bib-0004","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1093\/rheumatology\/kew300","article-title":"Elevated serum levels of free interleukin-18 in adult-onset Still's disease","volume":"55","author":"Girard","year":"2016","journal-title":"Rheumatology"},{"key":"2021121100032006500_cei13648-bib-0005","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3899\/jrheum.130575","article-title":"Interleukin 18: a biomarker for differential diagnosis between adult-onset Still's disease and sepsis","volume":"41","author":"Priori","year":"2014","journal-title":"J Rheumatol"},{"key":"2021121100032006500_cei13648-bib-0006","first-page":"2189","article-title":"Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease","volume":"31","author":"Chen","year":"2004","journal-title":"J Rheumatol"},{"key":"2021121100032006500_cei13648-bib-0007","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cytogfr.2009.02.004","article-title":"Interferon-gamma: a historical perspective","volume":"20","author":"Billiau","year":"2009","journal-title":"Cytokine Growth Factor Rev"},{"key":"2021121100032006500_cei13648-bib-0008","doi-asserted-by":"crossref","first-page":"46652","DOI":"10.1038\/srep46652","article-title":"Elevated circulating levels of the interferon-\u03b3-induced chemokines are associated with disease activity and cutaneous manifestations in adult-onset Still's disease","volume":"7","author":"Han","year":"2017","journal-title":"Sci Rep"},{"key":"2021121100032006500_cei13648-bib-0009","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3109\/03009742.2011.644325","article-title":"Neutrophil CD64 is upregulated in patients with active adult-onset Still's disease","volume":"41","author":"Komiya","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"2021121100032006500_cei13648-bib-0010","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.3899\/jrheum.181192","article-title":"Characteristics of circulating natural killer cells and their interferon-\u03b3 production in active adult-onset Still disease","volume":"46","author":"Shimojima","year":"2019","journal-title":"J Rheumatol"},{"key":"2021121100032006500_cei13648-bib-0011","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1136\/ard.2003.013680","article-title":"Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease","volume":"63","author":"Chen","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"2021121100032006500_cei13648-bib-0012","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1093\/rheumatology\/keq284","article-title":"Potential role of Th17 cells in the pathogenesis of adult-onset Still's disease","volume":"49","author":"Chen","year":"2010","journal-title":"Rheumatology"},{"key":"2021121100032006500_cei13648-bib-0013","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/jmcb\/mjr039","article-title":"Induced Foxp3(+) regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases?","volume":"4","author":"Lan","year":"2012","journal-title":"J Mol Cell Biol"},{"key":"2021121100032006500_cei13648-bib-0014","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"2021121100032006500_cei13648-bib-0015","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3109\/03008200903461462","article-title":"The associations of circulating CD4+CD25high regulatory T cells and TGF-\u03b2 with disease activity and clinical course in patients with adult-onset Still's disease","volume":"51","author":"Chen","year":"2010","journal-title":"Connect Tissue Res"},{"key":"2021121100032006500_cei13648-bib-0016","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12016-018-8721-0","article-title":"Regulatory T cell plasticity and stability and autoimmune diseases","volume":"58","author":"Qiu","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"key":"2021121100032006500_cei13648-bib-0017","doi-asserted-by":"crossref","first-page":"102461","DOI":"10.1016\/j.jaut.2020.102461","article-title":"The progress and prospect of regulatory T cells in autoimmune diseases","volume":"111","author":"Zhang","year":"2020","journal-title":"J Autoimmun"},{"key":"2021121100032006500_cei13648-bib-0018","first-page":"424","article-title":"Preliminary criteria for classification of adult Still's disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J Rheumatol"},{"key":"2021121100032006500_cei13648-bib-0019","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","article-title":"Adult Still's disease: manifestations, disease course, and outcome in 62 patients","volume":"70","author":"Pouchot","year":"1991","journal-title":"Medicine"},{"key":"2021121100032006500_cei13648-bib-0020","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3899\/jrheum.161286","article-title":"Application of the 2016 EULAR\/ACR\/PRINTO classification criteria for macrophage activation syndrome in patients with adult-onset Still disease","volume":"44","author":"Ahn","year":"2017","journal-title":"J Rheumatol"},{"key":"2021121100032006500_cei13648-bib-0021","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/art.39332","article-title":"2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation collaborative initiative","volume":"68","author":"Ravelli","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2021121100032006500_cei13648-bib-0022","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/14397595.2016.1172999","article-title":"Imbalanced expression of dysfunctional regulatory T cells and T-helper cells relates to immunopathogenesis in polyarteritis nodosa","volume":"27","author":"Shimojima","year":"2017","journal-title":"Mod Rheumatol"},{"key":"2021121100032006500_cei13648-bib-0023","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1172\/JCI84181","article-title":"NADPH oxidase deficiency underlies dysfunction of aged CD8+ Tregs","volume":"126","author":"Wen","year":"2016","journal-title":"J Clin Invest"},{"key":"2021121100032006500_cei13648-bib-0024","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12916-016-0738-8","article-title":"Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers","volume":"14","author":"Ruscitti","year":"2016","journal-title":"BMC Med"},{"key":"2021121100032006500_cei13648-bib-0025","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.autrev.2011.05.004","article-title":"Human FoxP3+ regulatory T cells in systemic autoimmune diseases","volume":"10","author":"Miyara","year":"2011","journal-title":"Autoimmun Rev"},{"key":"2021121100032006500_cei13648-bib-0026","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2567.2009.03213.x","article-title":"Patients with Wegener's granulomatosis demonstrate a relative deficiency and functional impairment of T-regulatory cells","volume":"130","author":"Morgan","year":"2010","journal-title":"Immunology"},{"key":"2021121100032006500_cei13648-bib-0027","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000355303","article-title":"Regulatory T cells and the immune aging process: a mini-review","volume":"60","author":"Jagger","year":"2014","journal-title":"Gerontology"},{"key":"2021121100032006500_cei13648-bib-0028","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nri2916","article-title":"Phenotypical and functional specialization of FOXP3+ regulatory T cells","volume":"11","author":"Campbell","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"2021121100032006500_cei13648-bib-0029","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fimmu.2012.00051","article-title":"Molecular mechanisms of Treg-mediated T cell suppression","volume":"3","author":"Schmidt","year":"2012","journal-title":"Front Immunol"},{"key":"2021121100032006500_cei13648-bib-0030","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/cei.12804","article-title":"Phenotypical characterization of regulatory T cells in humans and rodents","volume":"185","author":"Rodr\u00edguez-Perea","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"2021121100032006500_cei13648-bib-0031","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/imr.12175","article-title":"Lineage stability and phenotypic plasticity of Foxp3\u207a regulatory T cells","volume":"259","author":"Hori","year":"2014","journal-title":"Immunol Rev"},{"key":"2021121100032006500_cei13648-bib-0032","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3389\/fimmu.2020.01269","article-title":"Molecular insights into regulatory T-cell adaptation to self, environment, and host tissues: plasticity or loss of function in autoimmune disease","volume":"11","author":"Brown","year":"2020","journal-title":"Front Immunol"},{"key":"2021121100032006500_cei13648-bib-0033","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1161\/CIRCULATIONAHA.118.036524","article-title":"Protean functions and phenotypic plasticity of regulatory T cells in chronic ischemic heart failure","volume":"139","author":"Frangogiannis","year":"2019","journal-title":"Circulation"},{"key":"2021121100032006500_cei13648-bib-0034","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.autrev.2013.12.004","article-title":"Th17 and regulatory T cell balance in autoimmune and inflammatory diseases","volume":"13","author":"Noack","year":"2014","journal-title":"Autoimmun Rev"},{"key":"2021121100032006500_cei13648-bib-0035","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm.3432","article-title":"Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis","volume":"20","author":"Komatsu","year":"2014","journal-title":"Nat Med"},{"key":"2021121100032006500_cei13648-bib-0036","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nature05479","article-title":"Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression","volume":"445","author":"Wan","year":"2007","journal-title":"Nature"},{"key":"2021121100032006500_cei13648-bib-0037","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"2021121100032006500_cei13648-bib-0038","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/eji.200839196","article-title":"Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions","volume":"39","author":"Duarte","year":"2009","journal-title":"Eur J Immunol"},{"key":"2021121100032006500_cei13648-bib-0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035572","article-title":"Inflammation-driven reprogramming of CD4+ Foxp3+ regulatory T cells into pathogenic Th1\/Th17 T effectors is abrogated by mTOR inhibition in vivo","volume":"7","author":"Yurchenko","year":"2012","journal-title":"PLOS ONE"},{"key":"2021121100032006500_cei13648-bib-0040","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/eji.200838904","article-title":"Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation","volume":"39","author":"Hoffmann","year":"2009","journal-title":"Eur J Immunol"},{"key":"2021121100032006500_cei13648-bib-0041","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.immuni.2008.05.007","article-title":"Molecular antagonism and plasticity of regulatory and inflammatory T cell programs","volume":"29","author":"Yang","year":"2008","journal-title":"Immunity"},{"key":"2021121100032006500_cei13648-bib-0042","first-page":"396","article-title":"Elevated serum interleukin 6, interferon-gamma, and tumor necrosis factor-alpha levels in patients with adult Still's disease","volume":"25","author":"Hoshino","year":"1998","journal-title":"J Rheumatol"},{"key":"2021121100032006500_cei13648-bib-0043","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.clim.2004.03.023","article-title":"Adult Still's disease reflects a Th2 rather than a Th1 cytokine profile","volume":"112","author":"Saiki","year":"2004","journal-title":"Clin Immunol"},{"key":"2021121100032006500_cei13648-bib-0044","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/rheumatology\/40.12.1398","article-title":"Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease","volume":"40","author":"Fujii","year":"2001","journal-title":"Rheumatology"},{"key":"2021121100032006500_cei13648-bib-0045","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nm.2389","article-title":"Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease","volume":"17","author":"Dominguez-Villar","year":"2011","journal-title":"Nat Med"},{"key":"2021121100032006500_cei13648-bib-0046","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.immuni.2015.02.004","article-title":"Regulatory T cell reprogramming toward a Th2-cell-like lineage impairs oral tolerance and promotes food allergy","volume":"42","author":"Noval Rivas","year":"2015","journal-title":"Immunity"},{"key":"2021121100032006500_cei13648-bib-0047","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/nm.4147","article-title":"An asthma-associated IL4R variant exacerbates airway inflammation by promoting conversion of regulatory T cells to TH17-like cells","volume":"22","author":"Massoud","year":"2016","journal-title":"Nat Med"},{"key":"2021121100032006500_cei13648-bib-0048","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2008-01-133967","article-title":"Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells","volume":"112","author":"Koenen","year":"2008","journal-title":"Blood"},{"key":"2021121100032006500_cei13648-bib-0049","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3899\/jrheum.080537","article-title":"The mid-range of the adjusted level of ferritin can predict the chronic course in patients with adult onset Still's disease","volume":"36","author":"Lee","year":"2009","journal-title":"J Rheumatol"},{"key":"2021121100032006500_cei13648-bib-0050","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s10067-010-1516-1","article-title":"Clinical features and prognosis in adult-onset Still's disease: a study of 104 cases","volume":"29","author":"Kong","year":"2010","journal-title":"Clin Rheumatol"},{"key":"2021121100032006500_cei13648-bib-0051","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.07571","article-title":"Genetic and epigenetic variation in the lineage specification of regulatory T cells","volume":"4","author":"Arvey","year":"2015","journal-title":"eLife"},{"key":"2021121100032006500_cei13648-bib-0052","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.smim.2015.02.002","article-title":"Epigenetic and transcriptional control of Foxp3+ regulatory T cells","volume":"27","author":"Huehn","year":"2015","journal-title":"Semin Immunol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cei.13648","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cei.13648","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/206\/2\/184\/41591956\/cei13648.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/206\/2\/184\/41591956\/cei13648.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:25:29Z","timestamp":1641054329000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/206\/2\/184\/6431193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,12]]},"references-count":52,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,8,12]]},"published-print":{"date-parts":[[2021,10,12]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.13648","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,11]]},"published":{"date-parts":[[2021,8,12]]}}}